Aeterna Zentaris Inc. (AEZS)
NASDAQ: AEZS · IEX Real-Time Price · USD
1.950
-0.040 (-2.01%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Aeterna Zentaris Revenue

In the year 2023, Aeterna Zentaris had annual revenue of $4.50M, a decrease of -20.25%. Revenue in the quarter ending December 31, 2023 was $121.00K, a -95.13% decrease year-over-year.

Revenue (ttm)
$4.50M
Revenue Growth
-20.25%
P/S Ratio
2.11
Revenue / Employee
$374,833
Employees
12
Market Cap
9.50M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.50M-1.14M-20.25%
Dec 31, 20225.64M380.00K7.22%
Dec 31, 20215.26M1.61M44.03%
Dec 31, 20203.65M3.12M586.47%
Dec 31, 2019532.00K-26.35M-98.02%
Dec 31, 201826.88M25.96M2,812.35%
Dec 31, 2017923.00K12.00K1.32%
Dec 31, 2016911.00K366.00K67.16%
Dec 31, 2015545.00K534.00K4,854.55%
Dec 31, 201411.00K-6.16M-99.82%
Dec 31, 20136.18M4.12M200.78%
Dec 31, 20122.05M-2.65M-56.37%
Dec 31, 20114.71M-23.00M-83.02%
Dec 31, 201027.70M-35.53M-56.19%
Dec 31, 200963.24M24.76M64.35%
Dec 31, 200838.48M-3.59M-8.53%
Dec 31, 200742.07M3.27M8.43%
Dec 31, 200638.80M-6.01M-13.42%
Dec 31, 200544.81M1.84M4.28%
Dec 31, 200442.97M-75.77M-63.81%
Dec 31, 2003118.74M40.81M52.37%
Dec 31, 200277.93M44.22M131.18%
Dec 31, 200133.71M27.24M420.84%
Dec 31, 20006.47M1.73M36.49%
Dec 31, 19994.74M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molecular Templates 57.31M
Telesis Bio 27.51M
NeuroMetrix 5.90M
Vaccinex 570.00K
BioCardia 477.00K
Organovo Holdings 242.00K
Kazia Therapeutics 15.65K
Revenue Rankings